Finance

Lists
Why is MANE down 5.02%?
Dive Deeper
MANE:NYSE
Veradermics Inc
$ 116.26
-5.02%
(-6.14) 1D
$ 116.26
0.00% (0.00)
After hours
Closed: 10-р сарын 13, 16:00:03 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MANE...
Open
$ 121.17
High
$ 122.27
Low
$ 115.67
Mkt. cap
4.86 тэрбум
Avg. vol.
831.09 мян
Volume
845.11 мян
52-wk high
$ 136.72
52-wk low
$ 32.00
EPS
-$ 3.35
No. of employees
37
Open
$ 121.17
High
$ 122.27
Low
$ 115.67
Mkt. cap
4.86 тэрбум
Avg. vol.
831.09 мян
Volume
845.11 мян
52-wk high
$ 136.72
52-wk low
$ 32.00
EPS
-$ 3.35
No. of employees
37
News stories
From web sources and news partners
About Veradermics Inc
CEO-
Employees37
Founded2019
HeadquartersНью Хэйвен, Коннектикут, Америкийн Нэгдсэн Улс
SectorPharmaceutical industry
Websiteveradermics.com
Analyst ratings
Based on 5 analysts giving stock ratings to MANE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MANE in the last 3 months.
Highest
Current $ 116.26
$ 182.00 (+56.55%)
Average
$ 169.20 (+45.54%)
Lowest
$ 160.00 (+37.62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Geoff Meacham
Citi
Buy
Maintained
$ 160.00
+37.6%
09/15/2026
Roger Song
Jefferies
Buy
Maintained
$ 182.00
+56.5%
09/08/2026
Unknown Analyst
Jefferies
Buy
Maintained
$ 182.00
+56.5%
09/08/2026
Serge Belanger
Needham
Buy
Maintained
$ 164.00
+41.1%
08/12/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$ 170.00
+46.2%
08/11/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
$ 170.00
+46.2%
07/15/2026
Marc Goodman
Leerink Partners
Buy
Initiated
$ 75.00
-35.5%
03/02/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Initiated
-
-
03/01/2026
Last report
2026 оны 8-р сарын 11
Fiscal period
Q2 2026
-$ 0.58 / -$ 0.64
+9.56%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 6-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14.33 сая
18.19 сая
20.92 сая
18.61 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.74 сая
4.82 сая
8.94 сая
10.95 сая
Operating expense
16.07 сая
23.01 сая
29.86 сая
29.55 сая
Total operating expenses
16.07 сая
23.01 сая
29.86 сая
29.55 сая
Operating income
-16.07 сая
-23.01 сая
-29.86 сая
-29.55 сая
Other non operating income
325.00 мян
258.00 мян
149.00 мян
1.21 сая
EBT including unusual items
-15.64 сая
-21.85 сая
-27.23 сая
-23.50 сая
EBT excluding unusual items
-15.64 сая
-21.85 сая
-27.23 сая
-23.50 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15.64 сая
-21.85 сая
-27.23 сая
-23.50 сая
Net profit margin
-
-
-
-
Earnings per share
-
-104.54
-1.32
-0.58
Interest and investment income
103.00 мян
906.00 мян
2.48 сая
4.84 сая
Interest expense
-
-
-
-
Net interest expenses
103.00 мян
906.00 мян
2.48 сая
4.84 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google аппс